Showing 821-830 of 9751 results for "".
DermWireTV: Sanofi Genzyme & Regeneron Global AD Report; Hydroquinone; Pfizer NDA; VCS
https://practicaldermatology.com/topics/practice-management/dermwiretv-sanofi-genzyme-regeneron-global-ad-report-hydroquinone-pfizer-nda-vcs/19868/The “Improving Quality of Care in AD” report, commissioned and funded by Sanofi Genzyme & Regeneron and completed by KPMG, debuts at the annual meeting of the EADV. Changes to FDA regulations implemented as part of the CARES Act limit access to hydroquinone. This year’s Virtual Vegas Cosmetic SuMetabolomics Highlights: The Importance of Circadian Rhythm in Skin
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/metabolomics-highlights-the-importance-of-circadian-rhythm-in-skin/23126/New insights on the critical role of maintaining the natural rhythm of skin protection and repair.Sexual Wellness is a Dermatologic Legacy
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/sexual-wellness-is-a-dermatologic-legacy/20315/It should come as no surprise that dermatologists are applying energy-based devices to support sexual health and wellness. The specialty's legacy is rooted in sexual health.Galderma's Future, Allergan's Bonti Buy, and Sebacia Clearance
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-s-future-allergan-s-bonti-buy-and-sebacia-clearance--xgheloga/18233/Nestle's Board says it has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group's strategic scope and expects a review of strategic options for Nestlé Skin Health to be complete by mid-2019. Allergan is acquiring Bonti for 195 million dExploring Hydrochlorothiazide Use and Skin Cancer Risk
https://practicaldermatology.com/topics/skin-cancer-photoprotection/exploring-hydrochlorothiazide-use-and-skin-cancer-risk/20446/A commonly used antihypertensive appears to be linked to an increased risk of SCC. What should dermatologists do?ABD Eyes Mohs Certification, Sun's Ilumya Approved, FUE Update
https://practicaldermatology.com/topics/psoriasis/dermwiretv-abd-eyes-mohs-certification-sun-s-ilumya-approved-fue-update/18319/The American Board of Dermatology has notified the American Board of Medical Specialties it wants to offer a subspecialty certificate in Micrographic Dermatologic Surgery. Dermatologists react. Ilumya or tildrakizumab from Sun Pharma is approved for moderate to severe psoriasis. Medicine the MusicalAAD & Week of Science, ADCETRIS CTCL Data, SILIQ Pricing
https://practicaldermatology.com/topics/skin-cancer-photoprotection/-dermwiretv-aad-week-of-science-adcetris-ctcl-data-siliq-pricing/18482/It's the Week of Science. The American Academy of Dermatology has joined a large group of other medical group in supporting the March for Science and its principles. Adults with hyperpigmentation tend to use sunscreen, but they are less likely to use other UV avoidance strategies, new research in JADoctors Betrayed by Traditional Financial Strategies
https://practicaldermatology.com/topics/practice-management/doctors-betrayed-by-traditional-financial-strategies/20960/Part one of this two-part series explores why financial advice for the “average” consumer isn't always the best advice for dermatologists.To Be Shorr: Use Call Tracking Numbers to Measure Your Marketing ROI
https://practicaldermatology.com/topics/practice-management/to-be-shorr-use-call-tracking-numbers-to-measure-your-marketing-roi/18604/Tracking ROI on your marketing initiatives is an important but sometimes challenging undertaking. In this edition of "To Be Shorr," Mara Shorr, BS, CAC II-V shares tips for easily tracking your investments, including the use of call tracking numbers.The Dermatology Industry: A Status Report
https://practicaldermatology.com/topics/psoriasis/the-dermatology-industry-a-status-report/21072/The two companies that stole the spotlight in 2014 continue to drive industry news in the dermatology space.